from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3187/-

LFCtreatmentdescriptionclass of inhibitor

0.448

Amikacinug/mL Amikacintranslation

0.263

Cap5-10ug/mL Capreomycintranslation

0.012

Rox10-50 ug/mL Roxithromycintranslation

-0.244

SM2-5 ug/mL Streptomycintranslation

0.470

Tet5-10 ug/mL Tetracyclinetranslation

0.336

Rif0.2-5ug/mL Rifampicintranscription

-0.160

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.355

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.500

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.294

CPZ10-50 ug/mL Chlorpromazinerespiration

0.068

Clofazimine10-13 ug/mL Clofaziminerespiration

0.681

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.266

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.160

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.920

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.321

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.851

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.519

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.324

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.356

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.782

KCN5-20 ug/mL Potassium cyaniderespiration

0.448

NaN30.2-2 mM Sodium aziderespiration

1.012

Nigericin50 uM Nigericinrespiration

0.201

TRC10-150 ug/mL Triclosanrespiration

-0.603

TRZ10-25 ug/mL Thioridazinerespiration

2.474

Valinomycin0.5-10 uM Valinomycinrespiration

-0.499

ZnSO42 mM ZnSO4respiration

-0.725

menadione6-10 ug/mL Menadionerespiration

-0.416

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.081

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.298

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.267

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.524

NRP_1Non-replicating persistence stage 1dosRassociated

-0.382

Amp0.2mg/mL AmpicillincellWall

-0.252

Cephalexin20-100 ug/mL CephalexincellWall

0.461

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.097

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.247

EMB10-20 ug/mL EthambutolcellWall

-0.337

Eta12-40 ug/mL EthionamidecellWall

-0.029

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.275

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.809

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.858

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.259

BZA0.12 mg/mL BenzamidearomaticAmides

-0.157

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.571

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.360

H2O24 mM hydrogen peroxideDNAdamaging

-0.272

Levo10 ug/mL LevofloxacinDNAdamaging

-0.478

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.223

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.526

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.115

UVUV-irradiationDNAdamaging

-0.993

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.518

Antimycin12.5-50 ug/mL Antimycin A?

0.187

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.309

PA_110-50 ug/mL Antitubercular compound PA-1?

0.715

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.090

PA8240.2-2 ug/mL PA-824?

-0.594

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.197

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.384

Verapamil50 uM Verapamil?

0.158

mercaptoethanol2 mM 2-Mercaptoethanol?

0.484

methoxatin10-20 ug/mL Methoxatin?